Skip to main content

Table 2 Genotype distribution of the selected SNPs in the study participants (Part 1/2)

From: Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population

Selected SNP

Genotype distribution*

p for difference

SNP (ID)

Genotype

PTB patients, n (%)

LTBI controls n (%)

Healthy controls without MTB infection n (%)

IL1RN

TT

170 (85.0)

169 (85.8)

173 (88.3)

0.607§

9589 A/T

TA

29 (14.5)

28 (14.2)

23 (11.7)

0.432&

(rs454078)

AA

1 (0.5)

0

0

 

IL1B

CC

54 (27.0)

63 (32.0)

59 (30.1)

0.270§

-511 C/T

CT

96 (48.0)

97 (49.2)

99 (50.5)

0.393&

(rs16944)

TT

50 (25.0)

37 (18.8)

38 (19.4)

 

IL2

TT

89 (44.5)

90 (45.7)

87 (44.4)

0.972§

-330 T/G

TG

88 (44.0)

85 (43.2)

88 (44.9)

0.964&

(rs2069762)

GG

23 (11.5)

22 (11.2)

21 (10.7)

 

IL4

TT

120 (60.0)

106 (53.8)

105 (53.6)

0.456§

-589 C/T

TC

70 (35.0)

79 (40.1)

77 (39.3)

0.375&

(rs2243250)

CC

10 (5.0)

12 (6.1)

14 (7.1)

 

IL8

AA

74 (37.0)

75 (38.1)

68 (34.7)

0.967§

-251 T/A

AT

97 (48.5)

93 (47.2)

99 (50.5)

0.890&

(rs4073)

TT

29 (14.5)

29 (14.7)

29 (14.8)

 

IL8RB

TT

83 (41.5)

83 (42.1)

78 (39.8)

0.985§

1208 C/T

TC

85 (42.5)

82 (41.6)

88 (44.9)

0.891&

(rs1126579)

CC

32 (16.0)

32 (16.2)

30 (15.3)

 

IL10

TT

99 (49.5)

83 (42.1)

81 (41.3)

0.282§

-819 T/C

TC

80 (40.0)

94 (47.7)

87 (44.4)

0.217&

(rs1800871)

CC

21 (10.5)

20 (10.2)

28 (14.3)

 

IL10

TT

176 (88.0)

162 (82.2)

160 (81.6)

0.133§

-1082 A/G

TC

23 (11.5)

35 (17.8)

35 (17.9)

0.201&

(rs1800896)

CC

1 (0.5)

0

1 (0.5)

 

IL18

CC

157 (78.5)

147 (74.6)

152 (77.6)

0.648§

-137 G/C

CG

40 (20.0)

46 (23.4)

42 (21.4)

0.865&

(rs187238)

GG

3 (1.5)

4 (2.0)

2 (1.0)

 

IL18

CC

58 (29.0)

50 (25.4)

49 (25.0)

0.708§

-607 A/C

CA

99 (49.5)

101 (51.3)

101 (51.5)

0.658&

(rs1946518)

AA

43 (21.5)

46 (23.4)

46 (23.5)

 

TLR1

GG

90 (45.2)

90 (35.4)

74 (37.8)

0.325§

-7202 A/G

GA

84 (42.2)

91 (32.7)

103 (52.6)

0.117&

(rs5743551)

AA

25 (12.6)

16 (8.1)

19 (9.7)

 

TLR2

TT

97 (48.5)

102 (51.8)

97 (49.5)

0.657§

597 C/T

TC

83 (41.5)

73 (37.1)

81 (41.3)

0.956&

(rs3804099)

CC

20 (10.0)

22 (11.2)

18 (9.2)

 

TLR5

CC

189 (94.5)

189 (95.9)

188 (96.4)

0.502§

1174 C/T

CT

11 (5.5)

8 (4.1)

7 (3.6)

0.377&

(rs5744168)

TT

0

0

0

 

TLR9

AA

70 (35.0)

67 (34.0)

68 (34.7)

0.051§

1174 A/G

AG

89 (44.5)

106 (53.8)

95 (48.5)

0.592&

(rs352139)

GG

41 (20.5)

24 (12.2)

33 (16.8)

 

TLR9

GG

72 (36.0)

70 (35.5)

71 (36.2)

0.052§

1635 A/G

GA

88 (44.0)

104 (52.8)

93 (47.5)

0.608&

(rs352140)

AA

40 (20.0)

23 (11.7)

32 (16.3)

 
  1. Abbreviations: IL interleukin, IL1RN inteleukin 1 receptor antagonist; IL8RB interleukin 8 receptor beta; LTBI latent M. tuberculosis infection; MTB Mycobacterium tuberculosis, PTB pulmonary tuberculosis, SNP single nucleotide polymorphism, TB tuberculosis, TLR Toll-like receptor.
  2. *Sum may not always add up to total because of missing data.
  3. §p for difference between PTB patients and LTBI controls.
  4. &p for difference between PTB patients and Healthy controls without MTB infection.